The test provides a negative predictive value (NPV) of 92.5% and can help providers identify children who are unlikely to be ...

Taking the time to assess the effectiveness of programs can help nonprofits better ensure the impact of their efforts.

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase 2a trial – - Data presented at AACR 2023 supports ...

Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...

Newark Public Schools showed insufficient progress in student achievement, keeping it under an improvement plan that requires ...